← Back to all trials
Completed
NCT04855305
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Conditions: Interstitial Lung Diseases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 47
Sponsor: Bastiaan Driehuys
Location: Duke University Medical Center Durham North Carolina
Summary
The purpose of this multi-centered, NIH-sponsored study is to develop an optimal protocol for using noninvasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs).
Eligibility Criteria
Inclusion/Exclusion Criteria for Healthy Volunteers
Inclusion Criteria: Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the trial:
1. Outpatients of either gender, age greater than or equal to 18 years
2. Willing and able to give informed consent and adhere to visit/protocol schedules (Consent must be given before any study procedures are performed.)
3. Subject has no diagnosed pulmonary conditions
4. Subject has not smoked in the previous 5 years
5. Smoking history, if any, is less than or equal to 5 pack-years
6. No history of using other inhaled products more than 1 time per week for \> 1 year
Exclusion Criteria: Subjects presenting with any of the following will not be included in the trial:
1. Subject is less than 18 years old
2. MRI is contraindicated based on responses to MRI screening questionnaire
3. Subject is pregnant or lactating
4. Resting oxygen saturation on room air \
Source: ClinicalTrials.gov (NCT04855305). StuddyBuddy aggregates publicly available trial information.